← Moderna, Inc.

Moderna, Inc.

MRNA Cumulative FCF

The running total of free cash flow across the series, showing cumulative cash generated to date.

Latest Cumulative FCF: -$11.20B (2026Q2); -12.5% YoY.

Across the 14 quarters from 2023Q1 to 2026Q2, Cumulative FCF ranged from -$11.20B in 2026Q2 to -$1.34B in 2023Q1.

Revenue EPS Free Cash Flow Gross Margin FCF Margin Cumulative FCF Rule of 40
MRNA Cumulative FCF

Latest: -$11.20B (2026Q2)

Healthcare Comparison

1 / 3

Other MRNA Charts

More quarter-by-quarter fundamentals for Moderna, Inc.

1 / 6